The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
Open accessAbstract
Background—: The vascular remodeling responsible for pulmonary arterial hypertension (PAH) involves predominantly the accumulation of α-smooth muscle actin–expressing mesenchymal-like cells in obstructive pulmonary vascular lesions. Endothelial-to-mesenchymal transition (EndoMT) may be a source of those α-smooth muscle actin–expressing cells. Methods and Results—: In situ evidence of EndoMT in human PAH was obtained by using confocal microscopy of multiple fluorescent stainings at the arterial level, and by using transmission electron microscopy and correlative light and electron microscopy at the ultrastructural level. Findings were confirmed by in vitro analyses of human PAH and control cultured pulmonary artery endothelial cells. In addition, the mRNA and protein signature of EndoMT was recognized at the arterial and lung level by quantitative real-time polymerase chain reaction and Western blot analyses. We confirmed our human observations in established animal models of pulmonary hypertension (monocrotaline and SuHx). After establishing the first genetically modified rat model linked to BMPR2 mutations (BMPR2 Δ140Ex1/+ rats), we demonstrated that EndoMT is linked to alterations in signaling of BMPR2, a gene that is mutated in 70% of cases of familial PAH and in 10% to 40% of cases of idiopathic PAH. We identified molecular actors of this pathological transition, including twist overexpression and vimentin phosphorylation. We demonstrated that rapamycin partially reversed the protein expression patterns of EndoMT, improved experimental PAH, and decreased the migration of human pulmonary artery endothelial cells, providing the proof of concept that EndoMT is druggable. Conclusions—: EndoMT is linked to alterations in BPMR2 signaling and is involved in the occlusive vas cular remodeling of PAH, findings that may have therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationVimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557
Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases
Geurts, A. M., Cost, G. J., Freyvert, Y., Zeitler, B., Miller, J. C., Choi, V. M., Jenkins, S. S., Wood, A., Cui, X., Meng, X., et al. (2009) · Science · doi:10.1126/science.1172447 · Cited by 934
Self-citationMolecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Morrell, N. W., Adnot, S., Archer, S. L., Dupuis, J., Lloyd Jones, P., MacLean, M. R., McMurtry, I. F., Stenmark, K. R., Thistlethwaite, P. A., Weissmann, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.018 · Cited by 819
Self-citationStenmark, K. R., Meyrick, B., Galie, N., Mooi, W. J., & McMurtry, I. F. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2009 · Cited by 774
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 653
Genetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R., Grünig, E., Aldred, M., Geraci, M., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 616
Self-citationThe role of endothelial-to-mesenchymal transition in cancer progression
Potenta, S., Zeisberg, E., & Kalluri, R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604662 · Cited by 554
Post-translational modifications of intermediate filament proteins: mechanisms and functions
Snider, N. T., & Omary, M. B. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3753 · Cited by 524
Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension
Abe, K., Toba, M., Alzoubi, A., Ito, M., Fagan, K. A., Cool, C. D., Voelkel, N. F., McMurtry, I. F., & Oka, M. (2010) · Circulation · doi:10.1161/circulationaha.109.927681 · Cited by 510
Pietra, G. G., Edwards, W. D., Kay, J. M., Rich, S., Kernis, J., Schloo, B., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., & Detre, K. M. (1989) · Circulation · doi:10.1161/01.cir.80.5.1198 · Cited by 455
Frid, M. G., Kale, V. A., & Stenmark, K. R. (2002) · Circulation Research · doi:10.1161/01.res.0000021432.70309.28 · Cited by 422
Arciniegas, E., Frid, M. G., Douglas, I. S., & Stenmark, K. R. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00378.2006 · Cited by 341
DeRuiter, M. C., Poelmann, R. E., VanMunsteren, J. C., Mironov, V., Markwald, R. R., & Gittenberger-de Groot, A. C. (1997) · Circulation Research · doi:10.1161/01.res.80.4.444 · Cited by 333
Eddahibi, S., Guignabert, C., Barlier-Mur, A.-M., Dewachter, L., Fadel, E., Dartevelle, P., Humbert, M., Simonneau, G., Hanoun, N., Saurini, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591321 · Cited by 297
Self-citationNetworking galore: intermediate filaments and cell migration
Chung, B.-M., Rotty, J. D., & Coulombe, P. A. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.06.008 · Cited by 208
Targeted gene delivery of BMPR2 attenuates pulmonary hypertension
Reynolds, A. M., Holmes, M. D., Danilov, S. M., & Reynolds, P. N. (2012) · European Respiratory Journal · doi:10.1183/09031936.00187310 · Cited by 186
Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease
He, J., Xu, Y., Koya, D., & Kanasaki, K. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0781-0 · Cited by 167
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Houssaini, A., Abid, S., Mouraret, N., Wan, F., Rideau, D., Saker, M., Marcos, É., Tissot, C.-M., Dubois‐Randé, J., Amsellem, V., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0429oc · Cited by 151
Self-citationTreatment of pulmonary arterial hypertension with targeted therapies
O’Callaghan, D. S., Savale, L., Montani, D., Jaïs, X., Sitbon, O., Simonneau, G., & Humbert, M. J. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.104 · Cited by 149
Self-citationNicolls, M. R., Mizuno, S., Tarasevičienė-Stewart, L., Farkas, L., Drake, J. I., Husseini, A. A., Gomez‐Arroyo, J. G., Voelkel, N. F., & Bogaard, H. J. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.105031 · Cited by 109
Self-citationDiez, M., Musri, M. M., Ferrer, E., Barberà, J. A., & Peinado, V. I. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq236 · Cited by 108
Endothelial-Mesenchymal Transition Occurs during Embryonic Pulmonary Artery Development
Arciniegas, E., Neves, C. Y., Carrillo, L. M., Zambrano, E. A., & Ramírez, R. (2005) · Endothelium · doi:10.1080/10623320500227283 · Cited by 107
Nishimura, T., Faul, J. L., Berry, G. J., VEVE, I., Pearl, R. G., & Kao, P. N. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2006093 · Cited by 105
Paddenberg, R., Stieger, P., von Lilien, A.-L., Faulhammer, P., Goldenberg, A., Tillmanns, H., Kummer, W., & Braun-Dullaeus, R. C. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-15 · Cited by 104
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats
Price, L., Montani, D., Tchérakian, C., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00028310 · Cited by 98
Zhu, P., Huang, L., Ge, X., Yan, F., Wu, R., & Ao, Q. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00503.x · Cited by 96
Sakao, S., Taraseviciene‐Stewart, L., Cool, C. D., Tada, Y., Kasahara, Y., Kurosu, K., Tanabe, N., Takiguchi, Y., Tatsumi, K., Kuriyama, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8432com · Cited by 86
Gong, H., Gao, X., Feng, S., Siddiqui, M. R., Garcia, A. N., Bonini, M. G., Komarova, Y. A., Vogel, S. M., Mehta, D., & Malik, A. B. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131190 · Cited by 79
Electron microscopy of the plexiform lesion.
Smith, P. F., & Heath, D. (1979) · Thorax · doi:10.1136/thx.34.2.177 · Cited by 75
Ochoa, C. D., Wu, S., & Stevens, T. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1253452 · Cited by 74
Characterization of immunoglobulin heavy chain knockout rats
Ménoret, S., Iscache, A. L., Tesson, L., Remy, S., Usal, C., Osborn, M. J., Cost, G. J., Brüggemann, M., Buelow, R., & Anegón, I. (2010) · European Journal of Immunology · doi:10.1002/eji.201040939 · Cited by 64
Self-citationEverolimus in Patients with Severe Pulmonary Hypertension: A Safety and Efficacy Pilot Trial
Seyfarth, H., Hammerschmidt, S., Halank, M., Neuhaus, P., & Wirtz, H. R. W. (2013) · Pulmonary Circulation · doi:10.1086/674311 · Cited by 57
Gao, H., Zhang, J., Liu, T., & Shi, W. (2011) · Europe PMC (PubMed Central) · Cited by 37
Quantitative Aspects of Immunogold Labeling in Embedded and Nonembedded Sections
Rabouille, C. (2003) · Humana Press eBooks · doi:10.1385/1-59259-201-5:125 · Cited by 33
Cited by
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Humbert, M., Guignabert, C., Bonnet, S., Dorfmüller, P., Klinger, J. R., Nicolls, M. R., Olschewski, A. J., Pullamsetti, S. S., Schermuly, R. T., Stenmark, K. R., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01887-2018 · Cited by 1,281
Self-citationEndothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases
Piera-Velazquez, S., & Jimenez, S. A. (2019) · Physiological Reviews · doi:10.1152/physrev.00021.2018 · Cited by 662
Endothelial to Mesenchymal Transition in Cardiovascular Disease
Kovacic, J. C., Dimmeler, S., Harvey, R. P., Finkel, T., Aikawa, E., Krenning, G., & Baker, A. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.089 · Cited by 631
Evrard, S. M., Lecce, L., Michelis, K. C., Nomura-Kitabayashi, A., Pandey, G., Purushothaman, K.-R., d’Escamard, V., Li, J. R., Hadri, L., Fujitani, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11853 · Cited by 620
TGF-β Family Signaling in Tumor Suppression and Cancer Progression
Seoane, J., & Gomis, R. R. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022277 · Cited by 510
Metadata
- Authors
- Ranchoux, B., Antigny, F., Rucker-Martin, C., Hautefort, A., Péchoux, C., Bogaard, H. J., Dorfmüller, P., Remy, S., Lecerf, F., Planté, S., Chat, S., Fadel, E., Houssaini, A., Anegon, I., Adnot, S., Simonneau, G., Humbert, M., Cohen-Kaminsky, S., & Perros, F.
- Venue
- Circulation
- Published
- 2015-03-17
- Volume
- 131
- Issue
- 11
- Pages
- 1006-1018
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2089812396
- Cited by
- 576
- References
- 38
- FWCI
- 36.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.